Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

MD Gans, T Gavrilova - Paediatric respiratory reviews, 2020 - Elsevier
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …
被引用次数：231 相关文章

Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

MD Gans, T Gavrilova - Paediatric Respiratory Reviews, 2020 - einstein.elsevierpure.com
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …

Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes.

MD Gans, T Gavrilova - Paediatric Respiratory Reviews, 2019 - europepmc.org
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …

Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

MD Gans, T Gavrilova - Paediatric respiratory reviews, 2020 - scholarship.miami.edu
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …

Understanding the immunology of asthma: Pathophysiology, biomarkers, and treatments for asthma endotypes

MD Gans, T Gavrilova - Paediatric respiratory reviews, 2020 - pubmed.ncbi.nlm.nih.gov
Asthma is a common disease in paediatrics and adults with a significant morbidity, mortality,
and financial burden worldwide. Asthma is now recognized as a heterogeneous disease …